tirzepatide dry eyes and Comparative ocular outcomes of tirzepatide versus other anti-obesity medications in people with obesity What is the best approach

The biggest phase 3 clinical trial showed a 28.7% reduction in weight in participants with obesity or overweight

Common reasons for stopping include achievement of weight goals, intolerable side effects, cost or access issues, pregnancy planning, or patient preference

If dietary measures are not sufficient, over-the-counter osmotic laxatives can provide relief without interfering with the peptide mechanism

Aim for the same bedtime and rising time daily, including weekends

When discussing compounded tirzepatide with your provider, sharing your genetic and biomarker profile can support a more personalized decision-making process

Its highly effective in weight management, offering a new approach to those struggling with obesity or weight-related health issues